• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症病因、发病机制及预后转化研究的基础:生物样本库与癌症登记处标准化及基于人群的关联指南。

A basis for translational cancer research on aetiology, pathogenesis and prognosis: Guideline for standardised and population-based linkages of biobanks to cancer registries.

作者信息

Dillner Joakim

机构信息

BioBanking & Molecular Resource Infrastructure of Sweden (BBMRI.se), Karolinska Institutet, S-17177 Stockholm, Sweden.

出版信息

Eur J Cancer. 2015 Jun;51(9):1018-27. doi: 10.1016/j.ejca.2013.10.007. Epub 2013 Nov 13.

DOI:10.1016/j.ejca.2013.10.007
PMID:24239448
Abstract

Population-based cancer research is paramount for controlling cancer. Cancer research is increasingly dependent on access to biospecimens from subjects that have been followed-up for future health outcomes. This is achieved using longitudinal follow-up of cohorts and biobanks using cancer registry linkages. All over the world, more and more large population-based cohorts and advanced biobanking facilities are established. International standardisation and networking in the linkage of cohorts and biobanks to cancer registries is required in order to enable international cancer research and comparability of research results. An international operating procedure and standard minimum dataset for linkages of biobanks, cohorts and cancer registries is proposed. An internationally comparable provision of well characterised study bases for molecular cancer research will be an essential prerequisite for the success of translational medicine.

摘要

基于人群的癌症研究对于控制癌症至关重要。癌症研究越来越依赖于获取来自已对未来健康结果进行随访的受试者的生物样本。这是通过使用队列和生物样本库的纵向随访以及癌症登记链接来实现的。在世界各地,越来越多基于人群的大型队列和先进的生物样本库设施得以建立。为了促进国际癌症研究以及研究结果的可比性,需要在队列、生物样本库与癌症登记处的链接方面进行国际标准化和网络化。本文提出了生物样本库、队列与癌症登记处链接的国际操作程序和标准最小数据集。为分子癌症研究提供具有国际可比性的特征明确的研究基础,将是转化医学成功的重要前提。

相似文献

1
A basis for translational cancer research on aetiology, pathogenesis and prognosis: Guideline for standardised and population-based linkages of biobanks to cancer registries.癌症病因、发病机制及预后转化研究的基础:生物样本库与癌症登记处标准化及基于人群的关联指南。
Eur J Cancer. 2015 Jun;51(9):1018-27. doi: 10.1016/j.ejca.2013.10.007. Epub 2013 Nov 13.
2
Ensuring quality in studies linking cancer registries and biobanks.确保癌症登记处和生物库相关研究的质量。
Acta Oncol. 2010 Apr;49(3):368-77. doi: 10.3109/02841860903447069.
3
The interface of population-based cancer registries and biobanks in etiological and clinical research--current and future perspectives.基于人群的癌症登记处和生物库在病因和临床研究中的接口--当前和未来的视角。
Acta Oncol. 2010 Nov;49(8):1227-34. doi: 10.3109/0284186X.2010.496792. Epub 2010 Jun 29.
4
Nordic biological specimen banks as basis for studies of cancer causes and control--more than 2 million sample donors, 25 million person years and 100,000 prospective cancers.北欧生物样本库作为癌症病因与控制研究的基础——超过200万样本捐赠者、2500万人年以及10万例前瞻性癌症病例。
Acta Oncol. 2007;46(3):286-307. doi: 10.1080/02841860701203545.
5
EUROCOURSE recipe for cancer surveillance by visible population-based cancer RegisTrees in Europe: From roots to fruits.欧洲基于可见人群的癌症登记树进行癌症监测的EUROCOURSE方案:从根源到成果。
Eur J Cancer. 2015 Jun;51(9):1050-63. doi: 10.1016/j.ejca.2015.02.017. Epub 2015 Apr 29.
6
EUROCOURSE lessons learned from and for population-based cancer registries in Europe and their programme owners: Improving performance by research programming for public health and clinical evaluation.欧洲课程:欧洲基于人群的癌症登记处及其项目负责人的经验教训:通过公共卫生和临床评估的研究规划提高绩效。
Eur J Cancer. 2015 Jun;51(9):997-1017. doi: 10.1016/j.ejca.2015.02.018. Epub 2015 May 5.
7
Nordic biological specimen bank cohorts as basis for studies of cancer causes and control: quality control tools for study cohorts with more than two million sample donors and 130,000 prospective cancers.北欧生物样本库队列作为癌症病因与控制研究的基础:针对拥有超过两百万样本捐赠者和13万例前瞻性癌症病例的研究队列的质量控制工具
Methods Mol Biol. 2011;675:61-112. doi: 10.1007/978-1-59745-423-0_3.
8
The Organization of European Cancer Institute Pathobiology Working Group and its support of European biobanking infrastructures for translational cancer research.欧洲癌症研究所病理生物学工作组及其对欧洲转化癌症研究生物库基础设施的支持。
Cancer Epidemiol Biomarkers Prev. 2010 Apr;19(4):923-6. doi: 10.1158/1055-9965.EPI-10-0062. Epub 2010 Mar 23.
9
[Translational cancer research - biobanks in surgery].[转化癌症研究——外科领域的生物样本库]
Zentralbl Chir. 2013 Feb;138(1):1-3. doi: 10.1055/s-0033-1337675.
10
Evolutionary concepts in biobanking - the BC BioLibrary.生物库中的进化概念 - BC 生物库。
J Transl Med. 2009 Nov 12;7:95. doi: 10.1186/1479-5876-7-95.

引用本文的文献

1
Accelerating cancer genomics research in Sub-Saharan Africa.加速撒哈拉以南非洲地区的癌症基因组学研究。
Front Oncol. 2025 May 29;15:1531799. doi: 10.3389/fonc.2025.1531799. eCollection 2025.
2
An Exploration of the Utility and Impacts of Implementation Science Strategies by Cancer Registries for Healthcare Improvement: A Systematic Review.癌症登记处实施科学策略对医疗保健改善的效用与影响探索:一项系统综述
Int J Health Policy Manag. 2024;13:8297. doi: 10.34172/ijhpm.8297. Epub 2024 Oct 7.
3
Clinical Epidemiological Studies of Colorectal Cancer by Record Linkage of Cancer Registries and Biospecimen Data: A Systematic Review.
基于癌症登记和生物样本数据的记录链接的结直肠癌临床流行病学研究:系统评价。
Asian Pac J Cancer Prev. 2023 Dec 1;24(12):4017-4023. doi: 10.31557/APJCP.2023.24.12.4017.
4
Melanoma Epidemiology and Early Detection in Europe: Diversity and Disparities.欧洲黑色素瘤流行病学与早期检测:多样性与差异
Dermatol Pract Concept. 2020 Jun 29;10(3):e2020033. doi: 10.5826/dpc.1003a33. eCollection 2020 Jul.
5
Current status of site-specific cancer registry system for the clinical researches: aiming for future contribution by the assessment of present medical care.特定部位癌症登记系统在临床研究中的现状:旨在通过评估当前医疗水平为未来做出贡献。
Int J Clin Oncol. 2019 Sep;24(9):1161-1168. doi: 10.1007/s10147-019-01434-w. Epub 2019 Apr 22.
6
Cancer registries in Europe-going forward is the only option.欧洲的癌症登记处——继续前行是唯一的选择。
Ecancermedicalscience. 2016 May 12;10:641. doi: 10.3332/ecancer.2016.641. eCollection 2016.
7
Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker development.临床蛋白质组学标志物:在生物标志物开发的研究设计和技术考虑方面的相关问题。
Clin Transl Med. 2014 Mar 29;3(1):7. doi: 10.1186/2001-1326-3-7.